Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 'If not TB, what could it be?' Chest X-ray findings from the 2016 Kenya Tuberculosis Prevalence Survey.1 passage
• 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19.1 passage
• 'LungGENS': a web-based tool for mapping single-cell gene expression in the developing lung.1 passage
• 'S'-shaped curve: modelling trends in smoking prevalence, uptake and cessation in Great Britain from 1973 to 2016.1 passage
• (untitled)10 passages
• 12-month randomised controlled trial of ginseng extract for moderate COPD.1 passage
• 16S pan-bacterial PCR can accurately identify patients with ventilator-associated pneumonia.1 passage
• 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.1 passage
• A 4-year prospective evaluation of protocols to improve clinical outcomes for patients with lymphangioleiomyomatosis in a national clinical centre.1 passage
• A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial.1 passage
• A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB.1 passage
• A care-bundles approach to improving standard of care in AECOPD admissions: results of a national project.1 passage
• A chest physician's guide to mechanisms of sinonasal disease.1 passage
• A child chronic cough-specific quality of life measure: development and validation.1 passage
• A clustering approach to identify severe bronchiolitis profiles in children.1 passage
• A diagnostic model for chronic hypersensitivity pneumonitis.1 passage
• A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD.1 passage
• A new instrument to assess physician skill at chest tube insertion: the TUBE-iCOMPT.1 passage
• A novel immunomodulatory function of neutrophils on rhinovirus-activated monocytes in vitro.1 passage
• A population-based prospective cohort study examining the influence of early-life respiratory tract infections on school-age lung function and asthma.1 passage
• A pro-inflammatory role for the Frizzled-8 receptor in chronic bronchitis.1 passage
• A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL).1 passage
• A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations.1 passage
• A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD.1 passage
• A randomised controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome.1 passage
• A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.1 passage
• A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA).1 passage
• A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.1 passage
• A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the regulation of the inflammatory response in the lung.1 passage
• A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.1 passage
• A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer.1 passage
• A systematic review of the effectiveness of discharge care bundles for patients with COPD.1 passage
• A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial.1 passage
• A validation of the National Early Warning Score to predict outcome in patients with COPD exacerbation.1 passage
• Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.1 passage
• Accelerated ageing of the lung in COPD: new concepts.1 passage
• Acceptability of hygiene, face covering and social distancing interventions to prevent exacerbations in people living with airways diseases.1 passage
• Accuracy and precision of transcutaneous carbon dioxide monitoring: a systematic review and meta-analysis.1 passage
• Accuracy of FENO for diagnosing asthma: a systematic review.1 passage
• Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia--an observational cohort study.1 passage
• Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.1 passage
• Acute and sustained increase in endothelial biomarkers in COVID-19.1 passage
• Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits.1 passage
• Acute graft-versus-host disease following lung transplantation in a patient with a novel1 passage
• Adaptive servo ventilation for sleep apnoea in heart failure: the FACE study 3-month data.1 passage
• Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy.1 passage
• Adiposity and asthma in adults: a bidirectional Mendelian randomisation analysis of The HUNT Study.1 passage
• Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance.1 passage
• Admission to hospital in the UK at a weekend does not influence the prognosis of adults with community-acquired pneumonia.1 passage
• Adults miscoded and misdiagnosed as having pneumonia: results from the British Thoracic Society pneumonia audit.1 passage
• Advance care planning for patients with chronic respiratory diseases: a systematic review of preferences and practices.1 passage
• Advancing clinical development pathways for new CFTR modulators in cystic fibrosis.1 passage
• Adverse childhood experiences and asthma: trajectories in a national cohort.1 passage
• Aerobic training decreases bronchial hyperresponsiveness and systemic inflammation in patients with moderate or severe asthma: a randomised controlled trial.1 passage
• Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems.1 passage
• Air pollution affects lung cancer survival.1 passage
• Airborne occupational exposures and the risk of developing respiratory symptoms and airway obstruction in the Lifelines Cohort Study.1 passage
• Airflow limitation in people living with HIV and matched uninfected controls.1 passage
• Airflow obstruction, impaired lung function and risk of sudden cardiac death: a prospective cohort study.1 passage
• Airway epithelial phosphoinositide 3-kinase-δ contributes to the modulation of fungi-induced innate immune response.1 passage
• Airway inflammation in severe asthmatics with acid gastro-oesophageal reflux.1 passage
• Airway obstruction in young adults born extremely preterm or extremely low birth weight in the postsurfactant era.1 passage
• Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study.1 passage
• Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.1 passage
• Alleviating mechanical constraints to ventilation with heliox improves exercise endurance in adult survivors of very preterm birth.1 passage
• Altered airway ciliary orientation in patients with X-linked retinitis pigmentosa.1 passage
• Altered breathing mechanics and ventilatory response during exercise in children born extremely preterm.1 passage
• Altered gut-liver axis and hepatic adiponectin expression in OSAS: novel mediators of liver injury in paediatric non-alcoholic fatty liver.1 passage
• Altered lung structure and function in mid-childhood survivors of very preterm birth.1 passage
• Altered relaxation times in MRI indicate bronchopulmonary dysplasia.1 passage
• Ambient PM1 passage
• Ambient air pollution exposure and chronic bronchitis in the Lifelines cohort.1 passage
• Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study.1 passage
• Ambient heat and hospitalisation for COPD in Brazil: a nationwide case-crossover study.1 passage
• Ambulatory percutaneous lung biopsy with early discharge and Heimlich valve management of iatrogenic pneumothorax: more for less.1 passage
• Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.1 passage
• An enhanced care package to improve asthma management in Malawian children: a randomised controlled trial.1 passage
• An evaluation of tuberculosis contact investigations against national standards.1 passage
• Analysis of lung cancer risk model (PLCO1 passage
• Analysis of nocturnal actigraphic sleep measures in patients with COPD and their association with daytime physical activity.1 passage
• Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia.1 passage
• Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype.1 passage
• Antimicrobial peptides, disease severity and exacerbations in bronchiectasis.1 passage
• Applications of artificial intelligence and machine learning in respiratory medicine.1 passage
• Are aerosols generated during lung function testing in patients and healthy volunteers? Results from the AERATOR study.1 passage
• Are physical measures related to patient-centred outcomes in ARDS survivors?1 passage
• Are welders more at risk of respiratory infections? Findings from a cross-sectional survey and analysis of medical records in shipyard workers: the WELSHIP project.1 passage
• Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis.1 passage
• Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS.1 passage
• Assessing bronchodilator response in preschool children using spirometry.1 passage
• Assessing the association between bronchiolitis in infancy and recurrent wheeze: a whole English birth cohort case-control study.1 passage
• Assessing the extent of non-aggressive cancer in clinically detected stage I non-small cell lung cancer.1 passage
• Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia.1 passage
• Assessment of a rapid liquid-based cytology method for measuring sputum cell counts.1 passage
• Association between COPD exacerbations and lung function decline during maintenance therapy.1 passage
• Association between acute respiratory disease events and the1 passage
• Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study.1 passage
• Association between asthma and lung function in adolescents born very preterm: results of the EPIPAGE cohort study.1 passage
• Association between asthma, corticosteroids and allostatic load biomarkers: a cross-sectional study.1 passage
• Association between bacterial homoplastic variants and radiological pathology in tuberculosis.1 passage
• Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China.1 passage
• Association between lung function of school age children and short-term exposure to air pollution and pollen: the PARIS cohort.1 passage
• Association between particulate matter air pollution and lung cancer.1 passage
• Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.1 passage
• Association of asthma severity and educational attainment at age 6-7 years in a birth cohort: population-based record-linkage study.1 passage
• Association of circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis.1 passage
• Association of heated tobacco product use with tobacco use cessation in a Japanese workplace: a prospective study.1 passage
• Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans.1 passage
• Association of novel measures of sleep disturbances with blood pressure: the Multi-Ethnic Study of Atherosclerosis.1 passage
• Association of sleep characteristics with atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.1 passage
• Associations between emphysema-like lung on CT and incident airflow limitation: a general population-based cohort study.1 passage
• Associations of CT evaluations of antigravity muscles, emphysema and airway disease with longitudinal outcomes in patients with COPD.1 passage
• Asthma admission rates and patterns of salbutamol and inhaled corticosteroid prescribing in England from 2013 to 2017.1 passage
• Asthma and all-cause mortality in children and young adults: a population-based study.1 passage
• Asthma diagnosis: into the fourth dimension.1 passage
• Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.1 passage
• Asthma in Latin America.1 passage
• Asthma-COPD overlap 2015: now we are six.1 passage
• Asymptomatic subjects with airway obstruction have significant impairment at exercise.1 passage
• At-risk children with asthma (ARC): a systematic review.1 passage
• Attendees of Manchester's Lung Health Check pilot express a preference for community-based lung cancer screening.1 passage
• Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation.1 passage
• Autoadjusted versus fixed CPAP for obstructive sleep apnoea: a multicentre, randomised equivalence trial.1 passage
• Automated O1 passage
• Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial.1 passage
• BET proteins are associated with the induction of small airway fibrosis in COPD.1 passage
• BTS guideline on long-term macrolides in adults with respiratory disease: not quite a panacea.1 passage
• Balance impairment in individuals with COPD: a systematic review with meta-analysis.1 passage
• Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease.1 passage
• Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study.1 passage
• Bioaerosol production by patients with tuberculosis during normal tidal breathing: implications for transmission risk.1 passage
• Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis.1 passage
• Biomarkers of iron metabolism facilitate clinical diagnosis in1 passage
• Biomechanical CT metrics are associated with patient outcomes in COPD.1 passage
• Birth weight, early childhood growth and lung function in middle to early old age: 1946 British birth cohort.1 passage
• Blocking LOXL2 and TGFβ1 signalling induces collagen I turnover in precision-cut lung slices derived from patients with idiopathic pulmonary fibrosis.1 passage
• Blood RNA sequencing shows overlapping gene expression across COPD phenotype domains.1 passage
• Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD.1 passage
• Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease Duvoix Annelyse 1Dickens Jenny 1Haq Imran 1Mannino David 2Miller Bruce 3Tal-Singer Ruth 3Lomas33 passages
• Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS study.1 passage
• Body mass index status and peripheral airway obstruction in school-age children: a population-based cohort study.1 passage
• Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.1 passage
• British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations.1 passage
• British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together.1 passage
• British Thoracic Society community-acquired pneumonia care bundle: results of a national implementation project.1 passage
• British Thoracic Society guidelines for home oxygen use in adults.1 passage
• British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).1 passage
• Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population.1 passage
• Bronchiectasis and the risk of cardiovascular disease: a population-based study.1 passage
• Bronchiectasis severity correlates with outcome in patients with primary antibody deficiency.1 passage
• Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi trial): study design and rationale.1 passage
• Bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time detection tool for peripheral lung cancer.1 passage
• Bronchoscopic transparenchymal nodule access (BTPNA): first in human trial of a novel procedure for sampling solitary pulmonary nodules.1 passage
• Building toolkits for COPD exacerbations: lessons from the past and present.1 passage
• Burden of nosocomial COVID-19 in Wales: results from a multicentre retrospective observational study of 2508 hospitalised adults.1 passage
• CD4+T cells in ageing-associated interstitial lung abnormalities show evidence of pro-inflammatory phenotypic and functional profile.1 passage
• COPD assessment test for the evaluation of COVID-19 symptoms.1 passage
• COPD clinical control as a predictor of future exacerbations: concept validation in the SPARK study population.1 passage
• COPD discharge bundle and pulmonary rehabilitation referral and uptake following hospitalisation for acute exacerbation of COPD.1 passage
• COPD-derived fibroblasts secrete higher levels of senescence-associated secretory phenotype proteins.1 passage
• COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study.1 passage
• COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations.1 passage
• COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.1 passage
• COVID-19: in the footsteps of Ernest Shackleton.1 passage
• CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension.1 passage
• CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry.1 passage
• CT pectoralis muscle area is associated with DXA lean mass and correlates with emphysema progression in a tobacco-exposed cohort.1 passage
• CT-derived muscle remodelling after bronchoscopic lung volume reduction in advanced emphysema.1 passage
• CTAS: a CT score to quantify disease activity in pulmonary sarcoidosis.1 passage
• CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis.1 passage
• Caffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ, and reduces established fibrosis in ex vivo precision-cut lung slices.1 passage
• Carbon footprint impact of the choice of inhalers for asthma and COPD.1 passage
• Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease.1 passage
• Centre at Guy's and St Thomas’ NHS Foundation Trust and King's College London, London, UKCorrespondence to28 passages
• Centre for Cancer Diagnosis in Primary Care, Aarhus University, Aarhus, Denmark8 Queens Centre for Oncology and Haematology, Hull and East25 passages
• Centre for Environmental Health, Institute of25 passages
• Centre in Microbial Diseases, National institute of Health Research, Royal Liverpool and Broadgreen University30 passages
• Centre, Nottingham University33 passages
• Centre, Oxford University, Oxford, UK3 Department of Pneumology, Biomedical Research26 passages
• Centre, Stevenage, Hertfordshire, UKCorrespondence to Professor29 passages
• Centre, University Hospital33 passages
• Centre, University Hospital of South13 passages
• Centre, University of Glasgow, Glasgow, UK3 Division of Population Health Sciences and Education, Population Health Research Centre, St George's University of London, London, UKCorrespondence to28 passages
• Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis.1 passage
• Change in biomarkers of type-2 inflammation following severe exacerbations of asthma.1 passage
• Change in pulmonary mechanics and the effect on breathing pattern of high flow oxygen therapy in stable hypercapnic COPD.1 passage
• Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study.1 passage
• Changes in asthma mortality in England and Wales since 2001.1 passage
• Changes in dynamic lung mechanics after lung volume reduction coil treatment of severe emphysema.1 passage
• Changing causes of death for patients with chronic respiratory disease in England, 2005-2015.1 passage
• Characterisation of gas exchange in COPD with dissolved-phase hyperpolarised xenon-129 MRI.1 passage
• Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era.1 passage
• Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study.1 passage
• Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.1 passage
• Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde.1 passage
• Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group.1 passage
• Chest radiographic abnormalities in HIV-infected African children: a longitudinal study.1 passage
• Childhood OSA is an independent determinant of blood pressure in adulthood: longitudinal follow-up study.1 passage
• Childhood pneumonia, pleurisy and lung function: a cohort study from the first to sixth decade of life.1 passage
• Children and young adults with CF in the USA have better lung function compared with the UK.1 passage
• Choking on a foreign body: a physiological study of the effectiveness of abdominal thrust manoeuvres to increase thoracic pressure.1 passage
• Cholesterol, lipoproteins and subclinical interstitial lung disease: the MESA study.1 passage
• Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers.1 passage
• Chronic airflow obstruction and ambient particulate air pollution.1 passage
• Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups.1 passage
• Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner.1 passage
• Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study.1 passage
• Chronic obstructive pulmonary disease and the risk of 12 cardiovascular diseases: a population-based study using UK primary care data.1 passage
• Chronotherapy for hypertension in obstructive sleep apnoea (CHOSA): a randomised, double-blind, placebo-controlled crossover trial.1 passage
• Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease.1 passage
• Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation.1 passage
• Circulating microbial cell-free DNA is associated with inflammatory host-responses in severe pneumonia.1 passage
• Clinical and functional differences between early-onset and late-onset adult asthma: a population-based Tasmanian Longitudinal Health Study.1 passage
• Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey.1 passage
• Clinical application of autologous technetium-99m-labelled eosinophils to detect focal eosinophilic inflammation in the lung.1 passage
• Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia.1 passage
• Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.1 passage
• Cluster-randomised trial of a nurse-led advance care planning session in patients with COPD and their loved ones.1 passage
• Cochrane corner: interventions for the management of malignant pleural effusions.1 passage
• Cochrane corner: psychological interventions for individuals with cystic fibrosis and their families.1 passage
• Coexistence of OSA may compensate for sleep related reduction in neural respiratory drive in patients with COPD.1 passage
• Combined impact of healthy lifestyle factors on risk of asthma, rhinoconjunctivitis and eczema in school children: ISAAC phase III.1 passage
• Combining clinical, radiological and genetic approaches to pneumothorax management.1 passage
• Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.1 passage
• Community-acquired pneumonia as medical emergency: predictors of early deterioration.1 passage
• Comorbidities, mortality and causes of death among patients with tuberculosis in Denmark 1998-2010: a nationwide, register-based case-control study.1 passage
• Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.1 passage
• Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules.1 passage
• Comparing cystic fibrosis outcomes across the pond Taylor-Robinson10 passages
• Comparing functional decline and distress from symptoms in people with thoracic life-limiting illnesses: lung cancers and non-malignant end-stage respiratory diseases.1 passage
• Comparing treatment effects of a convenient vibratory positional device to CPAP in positional OSA: a crossover randomised controlled trial.1 passage
• Comparison of a structured home-based rehabilitation programme with conventional supervised pulmonary rehabilitation: a randomised non-inferiority trial.1 passage
• Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score.1 passage
• Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort.1 passage
• Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial.1 passage
• Computerised clinical decision support for suspected PE.1 passage
• Contrast-enhanced ultrasound does not discriminate between community acquired pneumonia and lung cancer.1 passage
• Contribution of obstructive sleep apnoea to arterial stiffness: a meta-analysis using individual patient data.1 passage
• Correlating 3D morphology with molecular pathology: fibrotic remodelling in human lung biopsies.1 passage
• Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis.1 passage
• Cost saving of switching to equivalent inhalers and its effect on health outcomes.1 passage
• Cost-effectiveness of FENO-based and web-based monitoring in paediatric asthma management: a randomised controlled trial.1 passage
• Cost-effectiveness of domiciliary non-invasive ventilation in patients with chronic obstructive pulmonary disease.1 passage
• Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea.1 passage
• Council Clinical Trials Unit at UCL, London, UK14 Department of Histopathology, Papworth33 passages
• Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK) Heaney10 passages
• Cross-sectional and longitudinal associations between urinary zinc and lung function among urban adults in China.1 passage
• Cross-sectional study of reversible airway obstruction in LAM: better evidence is needed for bronchodilator and inhaled steroid use.1 passage
• Cured meat intake is associated with worsening asthma symptoms.1 passage
• Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people.1 passage
• Current understanding and management of pulmonary Langerhans cell histiocytosis.1 passage
• Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei.1 passage
• DNA methylation is associated with airflow obstruction in patients living with HIV.1 passage
• DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature.1 passage
• Damp mouldy housing and early childhood hospital admissions for acute respiratory infection: a case control study.1 passage
• Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor.1 passage
• Database (IORD)1 NIHR Oxford Biomedical Research Centre, Oxford, UK2 Nuffield Department of Medicine, University of Oxford, Oxford, UK3 Oxford University35 passages
• Decrease in an anti-ageing factor, growth differentiation factor 11, in chronic obstructive pulmonary disease.1 passage
• Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study.1 passage
• Decreased glutathione and low catalase activity contribute to oxidative stress in children with α-1 antitrypsin deficiency.1 passage
• Decreased lung function in 7-year-old children with early-life organophosphate exposure.1 passage
• Deficient retinoid-driven angiogenesis may contribute to failure of adult human lung regeneration in emphysema.1 passage
• Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis http://orcid.org/0000-0002-2203-2703Gray32 passages
• Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis.1 passage
• Delivery of long-term-injectable agents for TB by lay carers: pragmatic randomised trial.1 passage
• Detection of early subclinical lung disease in children with cystic fibrosis by lung ventilation imaging with hyperpolarised gas MRI.1 passage
• Determinants of early-life lung function in African infants.1 passage
• Development and first validation of a patient-reported experience measure in chronic obstructive pulmonary disease (PREM-C9).1 passage
• Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score.1 passage
• Developmental determinants in non-communicable chronic diseases and ageing.1 passage
• Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort.1 passage
• Diagnostic accuracy of a two-stage model for detecting obstructive sleep apnoea in chronic tetraplegia.1 passage
• Diagnostic accuracy of focused deep venous, lung, cardiac and multiorgan ultrasound in suspected pulmonary embolism: a systematic review and meta-analysis.1 passage
• Diagnostic accuracy of interleukin 27 for tuberculous pleural effusion: two prospective studies and one meta-analysis.1 passage
• Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia.1 passage
• Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.1 passage
• Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group.1 passage
• Diesel exhaust augments allergen-induced lower airway inflammation in allergic individuals: a controlled human exposure study.1 passage
• Dietary nitrate supplementation to enhance exercise capacity in hypoxic COPD: EDEN-OX, a double-blind, placebo-controlled, randomised cross-over study.1 passage
• Differences in lung function between children with sickle cell anaemia from West Africa and Europe.1 passage
• Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations.1 passage
• Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis.1 passage
• Diffuse cystic lung disease in sickle cell anaemia: a series of 22 cases and a case-control study.1 passage
• Disadvantage in early-life and persistent asthma in adolescents: a UK cohort study.1 passage
• Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening.1 passage
• Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.1 passage
• Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19.1 passage
• Distinct severity stages of obstructive sleep apnoea are correlated with unique dyslipidaemia: large-scale observational study.1 passage
• Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts.1 passage
• Does household use of biomass fuel cause lung cancer? A systematic review and evaluation of the evidence for the GBD 2010 study.1 passage
• Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?1 passage
• Does training respiratory physicians in clinical respiratory physiology and interpretation of pulmonary function tests improve core knowledge?1 passage
• Double-blind randomised controlled trial of vitamin D3 supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu).1 passage
• Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs).1 passage
• Drive-through testing for SARS-CoV-2 in symptomatic health and social care workers and household members: an observational cohort study.1 passage
• Duration of neonatal oxygen supplementation, erythropoiesis and blood pressure in young adults born preterm.1 passage
• Duration of the efficacy of omalizumab after treatment discontinuation in 'real life' severe asthma.1 passage
• Dynamic laryngeal narrowing during exercise: a mechanism for generating intrinsic PEEP in COPD?1 passage
• Dysregulation of prostaglandins, leukotrienes and lipoxin A1 passage
• EBUS-guided mediastinal lung cancer staging: monitoring of quality standards improves performance.1 passage
• Early nasal microbiota and acute respiratory infections during the first years of life.1 passage
• Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score.1 passage
• Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial.1 passage
• Early-life risk factors for reversible and irreversible airflow limitation in young adults: findings from the BAMSE birth cohort.1 passage
• Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome.1 passage
• Economic burden of multimorbidity in patients with severe asthma: a 20-year population-based study.1 passage
• Educational video to improve CPAP use in patients with obstructive sleep apnoea at risk for poor adherence: a randomised controlled trial.1 passage
• Effect and impact of mechanical ventilation in myotonic dystrophy type 1: a prospective cohort study.1 passage
• Effect modification of greenness on PM1 passage
• Effect modifiers of lung function and daily air pollutant variability in a panel of schoolchildren.1 passage
• Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial.1 passage
• Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma.1 passage
• Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.1 passage
• Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.1 passage
• Effect of exposure to fine particulate matter during pregnancy and infancy on paediatric allergic rhinitis.1 passage
• Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis.1 passage
• Effect of mandibular advancement therapy on inflammatory and metabolic biomarkers in patients with severe obstructive sleep apnoea: a randomised controlled trial.1 passage
• Effect of nusinersen on respiratory function in paediatric spinal muscular atrophy types 1-3.1 passage
• Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis.1 passage
• Effect of quitting smoking on health outcomes during treatment for tuberculosis: secondary analysis of the TB & Tobacco Trial.1 passage
• Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis.1 passage
• Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial.1 passage
• Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung.1 passage
• Effectiveness of a brief community outreach tobacco cessation intervention in India: a cluster-randomised controlled trial (the BABEX Trial).1 passage
• Effectiveness of an exercise programme on physical function in patients discharged from hospital following critical illness: a randomised controlled trial (the REVIVE trial).1 passage
• Effectiveness of chemical pleurodesis in spontaneous pneumothorax recurrence prevention: a systematic review.1 passage
• Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case-control study.1 passage
• Effectiveness of school-based self-management interventions for asthma among children and adolescents: findings from a Cochrane systematic review and meta-analysis.1 passage
• Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials.1 passage
• Effects of CPAP therapy withdrawal on exhaled breath pattern in obstructive sleep apnoea.1 passage
• Effects of Wnt signaling on epithelial to mesenchymal transition in chronic rhinosinusitis with nasal polyp.1 passage
• Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial.1 passage
• Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis.1 passage
• Effects of mindfulness training programmes delivered by a self-directed mobile app and by telephone compared with an education programme for survivors of critical illness: a pilot randomised clinical trial.1 passage
• Effects of tobacco smoking on recurrent hospitalisation with pneumonia: a population-based cohort study.1 passage
• Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis.1 passage
• Efficacy and safety of lower versus higher CO1 passage
• Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.1 passage
• Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis.1 passage
• Efficacy of unsupervised exercise in adults with obstructive lung disease: a systematic review and meta-analysis.1 passage
• Elective extra corporeal membrane oxygenation for high-risk rigid bronchoscopy.1 passage
• Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers.1 passage
• Emphysema: time to say farewell to therapeutic nihilism Zoumot Zaid Jordan Simon Hopkinson10 passages
• Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis.1 passage
• End-of-life care in oxygen-dependent ILD compared with lung cancer: a national population-based study.1 passage
• Endobronchial valves for patients with heterogeneous emphysema and without interlobar collateral ventilation: open label treatment following the BeLieVeR-HIFi study.1 passage
• Endocrine responses during CPAP withdrawal in obstructive sleep apnoea: data from two randomised controlled trials.1 passage
• Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma.1 passage
• Endoscopic advanced imaging of the respiratory tract: exploring probe-based confocal laser endomicroscopy in emphysema.1 passage
• Energy conservation technique improves dyspnoea when patients with severe COPD climb stairs: a randomised crossover study.1 passage
• Environmental exposures and systemic hypertension are risk factors for decline in lung function.1 passage
• Eosinophilia and fractional exhaled nitric oxide levels in chronic obstructive lung disease.1 passage
• Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait.1 passage
• Epidemiology and prognostic factors of pleural empyema.1 passage
• Epidemiology of spontaneous pneumothorax: gender-related differences.1 passage
• Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis.1 passage
• Essential role of smooth muscle Rac1 in severe asthma-associated airway remodelling.1 passage
• Ethics, consent and blinding: lessons from a placebo/sham controlled CPAP crossover trial.1 passage
• European protocols for the diagnosis and initial treatment of interstitial lung disease in children.1 passage
• Evaluating latent tuberculosis infection diagnostics using latent class analysis.1 passage
• Evaluation of cardiovascular risk in a lung cancer screening cohort.1 passage
• Evidence for a genetical contribution to non-smoking-related lung cancer.1 passage
• Evidence for chemokine synergy during neutrophil migration in ARDS.1 passage
• Evidence for multiple cases of recurrent1 passage
• Exacerbation risk and characterisation of the UK's asthma population from infants to old age.1 passage
• Exercise as a substitute for traditional airway clearance in cystic fibrosis: a systematic review.1 passage
• Exercise-induced haemoptysis as a rare presentation of a rare lung disease.1 passage
• Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12.1 passage
• Experimental and quantitative imaging techniques in interstitial lung disease.1 passage
• Experimental modulation of mood by acoustic stimulation and its effect on exertional dyspnoea.1 passage
• Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF.1 passage
• Exploring the challenges of accessing medication for patients with cystic fibrosis.1 passage
• Exposure of patients to ionising radiation during lung cancer diagnostic work-up.1 passage
• Expression network analysis reveals cord blood vitamin D-associated genes affecting risk of early life wheeze.1 passage
• Extensive global movement of multidrug-resistant1 passage
• Extensive global movement of multidrug-resistant M. tuberculosis strains revealed by whole-genome analysis Cohen29 passages
• External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.1 passage
• External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules.1 passage
• External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.1 passage
• External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland.1 passage
• Extracorporeal CO1 passage
• FLCN-regulated miRNAs suppressed reparative response in cells and pulmonary lesions of Birt-Hogg-Dubé syndrome.1 passage
• Familial pneumothorax: towards precision medicine.1 passage
• Farewell, king coal!1 passage
• Fas activation alters tight junction proteins in acute lung injury.1 passage
• Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.1 passage
• Fellow1Keall Michael 2Jones Bernadette 1Aldridge36 passages
• Fellowship programme and Novartis28 passages
• Fibrinogen and α1-antitrypsin in COPD exacerbations.1 passage
• Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.1 passage
• Fibrotic extracellular matrix induces release of extracellular vesicles with pro-fibrotic miRNA from fibrocytes.1 passage
• Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.1 passage
• Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort study.1 passage
• Five-year outcome of respiratory muscle weakness at intensive care unit discharge: secondary analysis of a prospective cohort study.1 passage
• Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial.1 passage
• Frailty after lung transplantation is associated with impaired health-related quality of life and mortality.1 passage
• Frailty subtypes and recovery in older survivors of acute respiratory failure: a pilot study.1 passage
• Framework for patient-ventilator asynchrony during long-term non-invasive ventilation.1 passage
• From skeletal muscle weakness to functional outcomes following critical illness: a translational biology perspective.1 passage
• Fruit and vegetable consumption and risk of COPD: a prospective cohort study of men.1 passage
• Functional brain imaging in respiratory medicine.1 passage
• Functional electrical stimulation in-bed cycle ergometry in mechanically ventilated patients: a multicentre randomised controlled trial.1 passage
• Functional electrical stimulation-assisted cycle ergometry-based progressive mobility programme for mechanically ventilated patients: randomised controlled trial with 6 months follow-up.1 passage
• Functional phenotypes determined by fluctuation-based clustering of lung function measurements in healthy and asthmatic cohort participants.1 passage
• Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19.1 passage
• GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation.1 passage
• Gait speed and pedestrian crossings in COPD.1 passage
• Gait speed and readmission following hospitalisation for acute exacerbations of COPD: a prospective study.1 passage
• Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review.1 passage
• Gastro-oesophageal reflux and worse asthma control in obese children: a case of symptom misattribution?1 passage
• Gender-based differences in community-wide screening for pulmonary tuberculosis in Karachi, Pakistan: an observational study of 311 732 individuals undergoing screening.1 passage
• Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiency.1 passage
• Gene correlation network analysis to identify regulatory factors in idiopathic pulmonary fibrosis.1 passage
• Genetic and observational evidence supports a causal role of sex hormones on the development of asthma.1 passage
• Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD.1 passage
• Genetic polymorphism in1 passage
• Genetic variants affecting cross-sectional lung function in adults show little or no effect on longitudinal lung function decline.1 passage
• Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank.1 passage
• Genome-wide association study of non-tuberculous mycobacterial pulmonary disease.1 passage
• Geo-social gradients in predicted COVID-19 prevalence in Great Britain: results from 1 960 242 users of the COVID-19 Symptoms Study app.1 passage
• Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients.1 passage
• Geospatial and seasonal variation of bronchiolitis in England: a cohort study using hospital episode statistics.1 passage
• Global and regional burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2019: results from the Global Burden of Disease study 2019.1 passage
• Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trial.1 passage
• Grandmaternal smoking, asthma and lung function in the offspring: the Lifelines cohort study.1 passage
• Grandmother's smoking when pregnant with the mother and asthma in the grandchild: the Norwegian Mother and Child Cohort Study.1 passage
• Greater parallel heterogeneity of airway narrowing and airway closure in asthma measured by high-resolution CT.1 passage
• Greenness may improve lung health in low-moderate but not high air pollution areas: Seven Northeastern Cities' study.1 passage
• Group, Mater Research University of Queensland, South Brisbane, Australia15 Children's Hospital Traunstein, Ludwig Maximilian's University, Munich, Germany16 Department of Adult Intensive Care,38 passages
• GroupSamet Jonathon Puhan Milo Hamid Qutayba Hogg39 passages
• Groups, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UKCorrespondence to:27 passages
• Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure.1 passage
• Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension.1 passage
• Guideline update: The British Thoracic Society Guidelines on home oxygen use in adults.1 passage
• Has growth in electronic cigarette use by smokers been responsible for the decline in use of licensed nicotine products? Findings from repeated cross-sectional surveys.1 passage
• Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population Kerkhof Marjan 1Tran39 passages
• Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population.1 passage
• Healthcare system encounters before COPD diagnosis: a registry-based longitudinal cohort study.1 passage
• Heat-moulded versus custom-made mandibular advancement devices for obstructive sleep apnoea: a randomised non-inferiority trial.1 passage
• Help, hinder, hide and harm: what can we learn from the interactions between1 passage
• Heparan sulfate chains contribute to the anticoagulant milieu in malignant pleural effusion.1 passage
• Hermansky-Pudlak syndrome with a novel genetic variant in1 passage
• Heterogeneity of respiratory disease in children and young adults with sickle cell disease.1 passage
• Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.1 passage
• High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice Schlosser Kenny 1Taha Mohamad 12Deng Yupu 1McIntyre42 passages
• High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice.1 passage
• High levels of indium exposure relate to progressive emphysematous changes: a 9-year longitudinal surveillance of indium workers.1 passage
• High prevalence of1 passage
• High prevalence of TB disease in contacts of adults with extrapulmonary TB.1 passage
• High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population.1 passage
• High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial.1 passage
• High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection.1 passage
• High-intensity training following lung cancer surgery: a randomised controlled trial.1 passage
• Higher cough flow is associated with lower risk of pneumonia in acute stroke.1 passage
• Higher exhaled nitric oxide at 6 weeks of age is associated with less bronchiolitis and wheeze in the first 12 months of age.1 passage
• Histologist's original opinion compared with multidisciplinary team in determining diagnosis in interstitial lung disease.1 passage
• Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients.1 passage
• Holistic services for people with advanced disease and chronic breathlessness: a systematic review and meta-analysis.1 passage
• Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial.1 passage
• Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation.1 passage
• Home versus outpatient pulmonary rehabilitation in COPD: a propensity-matched cohort study.1 passage
• Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial.1 passage
• Hormonal contraception and the risk of severe asthma exacerbation: 17-year population-based cohort study.1 passage
• Household disposable income and long-term survival after pulmonary resections for lung cancer.1 passage
• Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat.1 passage
• Human tissue models for a human disease: what are the barriers?1 passage
• Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF.1 passage
• Hypoxia and tissue destruction in pulmonary TB.1 passage
• Hypoxia upregulates neutrophil degranulation and potential for tissue injury.1 passage
• Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis.1 passage
• Identification of eight-protein biosignature for diagnosis of tuberculosis.1 passage
• Identifying areas and risk groups with localised Mycobacterium tuberculosis transmission in northern England from 2010 to 2012: spatiotemporal analysis incorporating highly discriminatory genotyping data.1 passage
• Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model.1 passage
• Identifying patients at risk of post-discharge complications related to COVID-19 infection.1 passage
• Identifying preventable risk factors for hospitalised asthma in young Aboriginal children: a whole-population cohort study.1 passage
• Immature monocytes contribute to cardiopulmonary bypass-induced acute lung injury by generating inflammatory descendants.1 passage
• Immunomodulatory innate defence regulator (IDR) peptide alleviates airway inflammation and hyper-responsiveness.1 passage
• Impact of COVID-19 lockdown on emergency asthma admissions and deaths: national interrupted time series analyses for Scotland and Wales.1 passage
• Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data.1 passage
• Impact of TB on the survival of people living with HIV infection in England, Wales and Northern Ireland.1 passage
• Impact of an increase in the inhaled corticosteroid dose on blood eosinophils in asthma.1 passage
• Impact of banning smoking in cars with children on exposure to second-hand smoke: a natural experiment in England and Scotland.1 passage
• Impact of chronic use of heat-not-burn cigarettes on oxidative stress, endothelial dysfunction and platelet activation: the SUR-VAPES Chronic Study.1 passage
• Impact of cystic fibrosis on birthweight: a population based study of children in Denmark and Wales.1 passage
• Impact of improved cookstoves on women's and child health in low and middle income countries: a systematic review and meta-analysis.1 passage
• Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.1 passage
• Impact of lung function on cardiovascular diseases and cardiovascular risk factors: a two sample bidirectional Mendelian randomisation study.1 passage
• Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study.1 passage
• Impact of organisation and specialist service delivery on lung cancer outcomes.1 passage
• Impact of respiratory muscle training on respiratory muscle strength, respiratory function and quality of life in individuals with tetraplegia: a randomised clinical trial.1 passage
• Impaired lung repair during neutropenia can be reverted by matrix metalloproteinase-9.1 passage
• Implementation of targeted screening for lung cancer in a high-risk population within routine NHS practice using low-dose computed tomography.1 passage
• Implementation of the Needs Assessment Tool for patients with interstitial lung disease (NAT:ILD): facilitators and barriers.1 passage
• Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester.1 passage
• Incidence and recognition of acute respiratory distress syndrome in a UK intensive care unit.1 passage
• Incidence of primary graft dysfunction after lung transplantation is altered by timing of allograft implantation.1 passage
• Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study.1 passage
• Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality.1 passage
• Inconsistent relationship between depth of sedation and intensive care outcome: systematic review and meta-analysis.1 passage
• Increased advanced glycation end product and meat consumption is associated with childhood wheeze: analysis of the National Health and Nutrition Examination Survey.1 passage
• Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs.1 passage
• Increased risk of mycobacterial infections associated with anti-rheumatic medications.1 passage
• Increasing airway obstruction from 8 to 18 years in extremely preterm/low-birthweight survivors born in the surfactant era.1 passage
• Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998-2014.1 passage
• Increasing incidence of asbestosis worldwide, 1990-2017: results from the Global Burden of Disease study 2017.1 passage
• Induction of ferroptosis-like cell death of eosinophils exerts synergistic effects with glucocorticoids in allergic airway inflammation.1 passage
• Infant weight trajectories and early childhood wheezing: the NINFEA birth cohort study.1 passage
• Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy.1 passage
• Influence of muscle mass in the assessment of lower limb strength in COPD: validation of the prediction equation.1 passage
• Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.1 passage
• Inhaled nitric oxide improves the hepatopulmonary syndrome: a physiologic analysis.1 passage
• Inhibition of PDIA3 in club cells attenuates osteopontin production and lung fibrosis.1 passage
• Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.1 passage
• Inspiratory muscle training to enhance recovery from mechanical ventilation: a randomised trial.1 passage
• Institute for Prevention of Childrens' Allergy and Respiratory Diseases, Marien-Hospital, Wesel, Germany9 Allergy Centre, University Hospital of Linköping, Linkoping, SwedenCorrespondence to Professor27 passages
• Institute, Herston, Queensland, Australia6 Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, AustraliaCorrespondence to Dr29 passages
• Integrated proteogenomic approach identifying a protein signature of COPD and a new splice variant of SORBS1.1 passage
• Intensive versus standard physical rehabilitation therapy in the critically ill (EPICC): a multicentre, parallel-group, randomised controlled trial Wright33 passages
• Intensive versus standard physical rehabilitation therapy in the critically ill (EPICC): a multicentre, parallel-group, randomised controlled trial.1 passage
• Interaction between the promoter1 passage
• Interaction of vitamin E isoforms on asthma and allergic airway disease.1 passage
• Interactive effect between ATPase-related genes and early-life tobacco smoke exposure on bronchial hyper-responsiveness detected in asthma-ascertained families.1 passage
• Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: effects on frequency of acute exacerbation and all-cause hospital admission.1 passage
• International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety.1 passage
• International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.1 passage
• International management platform for children's interstitial lung disease (chILD-EU).1 passage
• Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT.1 passage
• Interstitial lung abnormalities and self-reported health and functional status.1 passage
• Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis.1 passage
• Intrapulmonary vascular shunt pathways in alveolar capillary dysplasia with misalignment of pulmonary veins.1 passage
• Intrauterine and early postnatal exposure to outdoor air pollution and lung function at preschool age.1 passage
• Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).1 passage
• Introduction of standardised packaging and availability of illicit cigarettes: a difference-in-difference analysis of European Union survey data 2015-2018.1 passage
• Investigating and managing suspected pulmonary embolism in an outpatient setting: the Leicester experience.1 passage
• Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study.1 passage
• Investigation of a unilateral pleural effusion: What CT scan coverage is optimal?1 passage
• Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer Lüchtenborg Margreet 12Morris37 passages
• Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.1 passage
• JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study.1 passage
• Lactate on emergency department arrival as a predictor of mortality and site-of-care in pneumonia patients: a cohort study.1 passage
• Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis.1 passage
• Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: a prospective study.1 passage
• Latent tuberculosis infection screening and treatment in HIV: insights from evaluation of UK practice.1 passage
• Latrophilin receptors: novel bronchodilator targets in asthma.1 passage
• Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.1 passage
• Leisure-time vigorous physical activity is associated with better lung function: the prospective ECRHS study Fuertes Elaine 123Carsin Anne-Elie 123Antó35 passages
• Leisure-time vigorous physical activity is associated with better lung function: the prospective ECRHS study.1 passage
• Lesson of the month: Rowing-induced laryngeal obstruction: a novel cause of exertional dyspnoea: characterised by direct laryngoscopy.1 passage
• Lesson of the month: management for aspiration of a silver nitrate pencil tip during tracheostomy care.1 passage
• Lesson of the month: novel method to quantify neutrophil uptake in early lung cancer using SPECT-CT.1 passage
• Lesson of the month: selective use of cyclophosphamide in pregnancy for severe autoimmune respiratory disease.1 passage
• Letter15062313Psychometric validation of the needs assessment tool: progressive disease in interstitial lung disease http://orcid.org/0000-0001-6204-9158Johnson14 passages
• Letter15062313The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers Rowbotham9 passages
• Letter16S pan-bacterial PCR can accurately identify patients with ventilator-associated pneumonia http://orcid.org/0000-0002-3211-3216Conway Morris Andrew 12Gadsby Naomi 3McKenna18 passages
• LetterCaffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ, and reduces established fibrosis in ex vivo precision-cut lung slices Tatler9 passages
• LetterChoking on a foreign body: a physiological study of the effectiveness of abdominal thrust manoeuvres to increase thoracic pressure Pavitt10 passages
• LetterCommunity-based recruitment of patients with COPD into clinical research Brill4 passages
• LetterDo guidelines for treating chest disease in children use Cochrane Reviews effectively? A systematic review http://orcid.org/0000-0002-1514-2840Prayle10 passages
• LetterImplementation of the Needs Assessment Tool for patients with interstitial lung disease (NAT:ILD): facilitators and barriers12 passages
• LetterNasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial Fraser10 passages
• LetterPhage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa http://orcid.org/0000-0002-6573-3462Waters8 passages
• LetterPrenatal origins of bronchiolitis: protective effect of optimised asthma management during pregnancy Mattes Joerg 123Murphy6 passages
• LetterSmokers are less likely than non-smokers to seek help for a lung cancer ‘alarm’ symptom Friedemann11 passages
• LetterThe cyclin-dependent kinase inhibitor AT7519 accelerates neutrophil apoptosis in sepsis-related acute respiratory distress syndrome http://orcid.org/0000-0002-4658-8829Dorward11 passages
• LetterThe impact of azithromycin therapy on the airway microbiota in asthma Slater Mariel 1Rivett5 passages
• LetterUnderweight as a risk factor for respiratory death in the Whitehall cohort study: exploring reverse causality using a 45-year follow-up Kivimäki Mika 1Shipley7 passages
• LettersIncidence and recognition of acute respiratory distress syndrome in a UK intensive care unit Summers Charlotte 12Singh11 passages
• LettersRecovery from pneumonia requires efferocytosis which is impaired in smokers and those with low body mass index and enhanced by statins Wootton10 passages
• Linear endobronchial ultrasonography: a novelty turned necessity for mediastinal nodal assessment.1 passage
• Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation.1 passage
• Long-term clinical outcomes of 'Prairie Epidemic Strain'1 passage
• Long-term follow-up after first-line bronchoscopic therapy in patients with bronchial carcinoids.1 passage
• Long-term impact of developing a postoperative pulmonary complication after lung surgery.1 passage
• Long-term persistence of human donor alveolar macrophages in lung transplant recipients.1 passage
• Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.1 passage
• Long-term quality-adjusted survival following therapeutic bronchoscopy for malignant central airway obstruction.1 passage
• Long-term survival following initiation of home non-invasive ventilation: a European study.1 passage
• Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension.1 passage
• Longer symptom onset to aspiration time predicts success of needle aspiration in primary spontaneous pneumothorax.1 passage
• Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis.1 passage
• Longitudinal changes to quadriceps thickness demonstrate acute sarcopenia following admission to hospital for an exacerbation of chronic respiratory disease.1 passage
• Longitudinal effects of ivacaftor and medicine possession ratio in people with the1 passage
• Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.1 passage
• Longitudinal shape irregularity of airway lumen assessed by CT in patients with bronchial asthma and COPD.1 passage
• Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension.1 passage
• Low serum IgA and airway injury in World Trade Center-exposed firefighters: a 17-year longitudinal study.1 passage
• Low vitamin D and risk of bacterial pneumonias: Mendelian randomisation studies in two population-based cohorts.1 passage
• Low-pathogenicity Mycoplasma spp. alter human monocyte and macrophage function and are highly prevalent among patients with ventilator-acquired pneumonia.1 passage
• Lung Gene Expression Analysis (LGEA): an integrative web portal for comprehensive gene expression data analysis in lung development.1 passage
• Lung Screen Uptake Trial: results from a single lung cancer screening round.1 passage
• Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening.1 passage
• Lung cancer stage-shift following a symptom awareness campaign.1 passage
• Lung cancer tissue diagnosis in poor lung function: addressing the ongoing percutaneous lung biopsy FEV1 paradox using Heimlich valve.1 passage
• Lung cancer, genetic predisposition and smoking: the Nordic Twin Study of Cancer.1 passage
• Lung clearance index predicts pulmonary exacerbations in individuals with primary ciliary dyskinesia: a multicentre cohort study.1 passage
• Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis.1 passage
• Lung consequences in adults born prematurely.1 passage
• Lung disease caused by1 passage
• Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men-the British Regional Heart Study.1 passage
• Lung function and asthma control in school-age children managed in UK primary care: a cohort study.1 passage
• Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.1 passage
• Lung function in children with sickle cell disease from Central Africa.1 passage
• Lung function in woodsmoke-exposed Guatemalan children following a chimney stove intervention.1 passage
• Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study.1 passage
• Lung function, airway and peripheral basophils and eosinophils are associated with molecular pharmacogenomic endotypes of steroid response in severe asthma.1 passage
• Lung health and exposure to air pollution in Malawian children (CAPS): a cross-sectional study.1 passage
• Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients.1 passage
• Lung sarcoidosis in children: update on disease expression and management.1 passage
• Lung structure-function correlation in patients with primary ciliary dyskinesia.1 passage
• Lung transplantation for acute exacerbation of interstitial lung disease.1 passage
• Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA.1 passage
• Lung volume indices predict morbidity in smokers with preserved spirometry.1 passage
• MRI of the upper airways in children and young adults: the MUSIC study.1 passage
• MRI ventilation abnormalities predict quality-of-life and lung function changes in mild-to-moderate COPD: longitudinal TINCan study.1 passage
• MTOR suppresses autophagy-mediated production of IL25 in allergic airway inflammation.1 passage
• MUC1 intracellular bioactivation mediates lung fibrosis.1 passage
• Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p.1 passage
• Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment.1 passage
• Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome.1 passage
• Majority of never-smokers with airflow limitation do not have asthma: the Copenhagen General Population Study.1 passage
• Management dilemmas in acute pulmonary embolism Condliffe Robin 12Elliot31 passages
• Management of obstructive sleep apnoea in a primary care vs sleep unit setting: a randomised controlled trial.1 passage
• Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT.1 passage
• Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review.1 passage
• Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA.1 passage
• Maternal history of miscarriages and measures of fertility in relation to childhood asthma.1 passage
• Maternal sleep-disordered breathing and the risk of delivering small for gestational age infants: a prospective cohort study.1 passage
• Measuring lung function in airways diseases: current and emerging techniques.1 passage
• Mechanical stress-induced mast cell degranulation activates TGF-β1 signalling pathway in pulmonary fibrosis.1 passage
• Mechanism of lung development in the aetiology of adult congenital pulmonary airway malformations.1 passage
• Mechanisms by which obesity impacts upon asthma.1 passage
• Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease?1 passage
• MesobanK UK: an international mesothelioma bioresource.1 passage
• Metabolic phenotype of skeletal muscle in early critical illness.1 passage
• Metal worker's lung: spatial association with1 passage
• Metal worker’s lung: spatial association with Mycobacterium avium James23 passages
• Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.1 passage
• Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.1 passage
• Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.1 passage
• Microfibrillar-associated protein 4 modulates airway smooth muscle cell phenotype in experimental asthma.1 passage
• Midlife cardiorespiratory fitness and the long-term risk of chronic obstructive pulmonary disease.1 passage
• Mind the gap: TB trends in the USA and the UK, 2000-2011.1 passage
• Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.1 passage
• Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomised controlled trials.1 passage
• Minimum important difference of the incremental shuttle walk test distance in patients with COPD.1 passage
• Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care.1 passage
• Modification of a domiciliary ventilator to increase FiO1 passage
• Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007-2010).1 passage
• Monitoring strategies in children with asthma: a randomised controlled trial.1 passage
• Morbidity and mortality associated with prescription cannabinoid drug use in COPD.1 passage
• Mortality from respiratory diseases associated with opium use: a population-based cohort study.1 passage
• Mortality reduction in adult community-acquired pneumonia in the UK (2009-2014): results from the British Thoracic Society audit programme.1 passage
• Mortality trends in women and men with COPD in Ontario, Canada, 1996-2012.1 passage
• Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.1 passage
• Mucoactive agents for acute respiratory failure in the critically ill: a systematic review and meta-analysis.1 passage
• Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.1 passage
• Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial.1 passage
• Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule?1 passage
• Multiple breath washout (MBW) testing using sulfur hexafluoride: reference values and influence of anthropometric parameters.1 passage
• Multiple, objectively measured sleep dimensions including hypoxic burden and chronic kidney disease: findings from the Multi-Ethnic Study of Atherosclerosis.1 passage
• NOTCH3 contributes to rhinovirus-induced goblet cell hyperplasia in COPD airway epithelial cells.1 passage
• Nanotechnology based therapeutics for lung disease.1 passage
• Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial.1 passage
• Nasal versus oronasal masks for home non-invasive ventilation in patients with chronic hypercapnia: a systematic review and individual participant data meta-analysis.1 passage
• Natural killer cells in lung transplantation.1 passage
• Neural correlates of cough hypersensitivity in humans: evidence for central sensitisation and dysfunctional inhibitory control.1 passage
• Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD.1 passage
• Neural respiratory drive predicts long-term outcome following admission for exacerbation of COPD: a post hoc analysis.1 passage
• Neutrophils in asthma: the good, the bad and the bacteria.1 passage
• Neutrophils in community-acquired pneumonia: parallels in dysfunction at the extremes of age.1 passage
• New forehead device in positional obstructive sleep apnoea: a randomised clinical trial.1 passage
• New reference ranges for interpreting forced expiratory manoeuvres in infants and implications for clinical interpretation: a multicentre collaboration.1 passage
• Night shift work is associated with an increased risk of asthma.1 passage
• Night-to-night variability of respiratory events in obstructive sleep apnoea: a systematic review and meta-analysis.1 passage
• Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume.1 passage
• Nocturnal hypoxaemia in interstitial lung disease: a systematic review.1 passage
• Non-coding RNA as lung disease biomarkers.1 passage
• Non-coding RNAs and respiratory disease.1 passage
• Non-coding RNAs in the pathogenesis of COPD.1 passage
• Non-communicable respiratory disease and air pollution exposure in Malawi: a prospective cohort study.1 passage
• Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study.1 passage
• Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea.1 passage
• Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis.1 passage
• Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury.1 passage
• Novel imaging detailing the origins of a pneumothorax.1 passage
• Novel pleural-bladder pump in malignant pleural effusions: from animal model to man.1 passage
• Novel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome.1 passage
• Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia.1 passage
• Nutrition and Exercise Rehabilitation in Obesity hypoventilation syndrome (NERO): a pilot randomised controlled trial.1 passage
• Obese individuals experience wheezing without asthma but not asthma without wheezing: a Mendelian randomisation study of 85,437 adults from the Copenhagen General Population Study.1 passage
• Objectively measured sleep characteristics and prevalence of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis Sleep study.1 passage
• Obstructive sleep apnoea and frequency of occupational injury.1 passage
• Obstructive sleep apnoea and quality of life in Ehlers-Danlos syndrome: a parallel cohort study.1 passage
• Obstructive sleep apnoea during REM sleep and incident non-dipping of nocturnal blood pressure: a longitudinal analysis of the Wisconsin Sleep Cohort.1 passage
• Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.1 passage
• Occupational exposure to inhaled pollutants and risk of airflow obstruction: a large UK population-based UK Biobank cohort.1 passage
• Occupational exposure to pesticides are associated with fixed airflow obstruction in middle-age.1 passage
• Occupational exposure to solvents and lung function decline: A population based study.1 passage
• Occupational exposures and 20-year incidence of COPD: the European Community Respiratory Health Survey.1 passage
• Occupational pesticide exposure and respiratory health: a large-scale cross-sectional study in three commercial farming systems in Ethiopia.1 passage
• Off-label use of inhaled tobramycin in Ontario, Canada.1 passage
• Olfactory dysfunction is worse in primary ciliary dyskinesia compared with other causes of chronic sinusitis in children.1 passage
• One evidence base; three stories: do opioids relieve chronic breathlessness?1 passage
• One-year change in health status and subsequent outcomes in COPD.1 passage
• One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD).1 passage
• One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.1 passage
• Oral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multicentre, double-blind, placebo-controlled, randomised parallel group study.1 passage
• Organophosphate and carbamate insecticide exposure is related to lung function change among smallholder farmers: a prospective study.1 passage
• Original articleAlveolar macrophage-derived microvesicles mediate acute lung injury Soni Sanooj Wilson30 passages
• Original articleAnti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype Birrell28 passages
• Original articleEffectiveness of chemical pleurodesis in spontaneous pneumothorax recurrence prevention: a systematic review41 passages
• Original articleEvidence for chemokine synergy during neutrophil migration in ARDS Williams31 passages
• Original articleLatrophilin receptors: novel bronchodilator targets in asthma33 passages
• Original articleLebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies Hanania30 passages
• Original articleNovel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome http://orcid.org/0000-0002-4658-8829Dorward35 passages
• Outcome of surgery versus radiotherapy after induction treatment in patients with N2 disease: systematic review and meta-analysis of randomised trials.1 passage
• Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis.1 passage
• Oxygen supplementation during exercise improves leg muscle fatigue in chronic fibrotic interstitial lung disease.1 passage
• PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.1 passage
• PRO: confronting resistance to rule-based medicine is essential to improving outcomes.1 passage
• Paediatric reproducibility limits for the forced expiratory volume in 1 s.1 passage
• Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention.1 passage
• Parameters recorded by software of non-invasive ventilators predict COPD exacerbation: a proof-of-concept study.1 passage
• Paraneoplastic phenomenon in mesothelioma.1 passage
• Parasternal electromyography to determine the relationship between patient-ventilator asynchrony and nocturnal gas exchange during home mechanical ventilation set-up.1 passage
• Parental psychological distress during pregnancy and the risk of childhood lower lung function and asthma: a population-based prospective cohort study.1 passage
• Parkin, an E3 ubiquitin ligase, enhances airway mitochondrial DNA release and inflammation.1 passage
• Particle depletion of diesel exhaust restores allergen-induced lung-protective surfactant protein D in human lungs.1 passage
• Patient gender bias on the diagnosis of idiopathic pulmonary fibrosis.1 passage
• Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort.1 passage
• Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.1 passage
• Patient outcomes from time of listing for lung transplantation in the UK: are there disease-specific differences?1 passage
• Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments.1 passage
• Patterns of breathlessness and associated consulting behaviour: results of an online survey.1 passage
• Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study.1 passage
• Per cent low attenuation volume and fractal dimension of low attenuation clusters on CT predict different long-term outcomes in COPD.1 passage
• Performance at stair-climbing test is associated with postoperative complications after lung resection: a systematic review and meta-analysis.1 passage
• Performance of QuantiFERON-1 passage
• Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis.1 passage
• Persistence of asthma following allergen avoidance is associated with proTh2 myeloid dendritic cell activation.1 passage
• Persistence of circulating endothelial microparticles in COPD despite smoking cessation.1 passage
• Persistence of immunity in children immunised with 13-valent pneumococcal conjugate vaccine and impact on nasopharyngeal carriage: a cross-sectional study.1 passage
• Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study.1 passage
• Persistent variations in national asthma mortality, hospital admissions and prevalence by socioeconomic status and region in England.1 passage
• Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.1 passage
• Perspectives of survivors, families and researchers on key outcomes for research in acute respiratory failure.1 passage
• Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial.1 passage
• Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study.1 passage
• Physical rehabilitation interventions for adult patients during critical illness: an overview of systematic reviews.1 passage
• Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS.1 passage
• Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial.1 passage
• PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.1 passage
• Plasma urate, lung function and chronic obstructive pulmonary disease: a Mendelian randomisation study in 114 979 individuals from the general population.1 passage
• Platypnoea-orthodeoxia syndrome: beware of investigations undertaken supine.1 passage
• Pleural procedures and patient safety: a national BTS audit of practice.1 passage
• Pleural recurrence after transthoracic needle lung biopsy in stage I lung cancer: a systematic review and individual patient-level meta-analysis.1 passage
• Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18.1 passage
• Pneumonia in low and middle income countries: progress and challenges25 passages
• Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea.1 passage
• Polysomnography versus limited respiratory monitoring and nurse-led titration to optimise non-invasive ventilation set-up: a pilot randomised clinical trial.1 passage
• Population-level impact of infant 10-valent pneumococcal conjugate vaccination on adult pneumonia hospitalisations in Finland.1 passage
• Positive airway pressure for sleep-disordered breathing in acute quadriplegia: a randomised controlled trial.1 passage
• Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England.1 passage
• Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension.1 passage
• Pott's disease: a major issue for an unaccompanied refugee minor.1 passage
• Predicting outcomes in primary spontaneous pneumothorax using air leak measurements.1 passage
• Predicting risk of unplanned hospital readmission in survivors of critical illness: a population-level cohort study.1 passage
• Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis.1 passage
• Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome.1 passage
• Predictors of mortality in Middle East respiratory syndrome (MERS).1 passage
• Pregnancy in lymphangioleiomyomatosis: clinical and lung function outcomes in two national cohorts.1 passage
• Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.1 passage
• Prevalence estimates and risk factors for early childhood wheeze across Europe: the EuroPrevall birth cohort.1 passage
• Prevalence of asthma-like symptoms with ageing http://orcid.org/0000-0002-1753-3896Jarvis Debbie 12Newson Roger 3Janson Christer 4Corsico Angelo 5Heinrich Joachim 6Anto42 passages
• Prevalence of asthma-like symptoms with ageing.1 passage
• Prevalence of exercise-induced bronchoconstriction and exercise-induced laryngeal obstruction in a general adolescent population.1 passage
• Prevalence of smoking among patients treated in NHS hospitals in England in 2010/2011: a national audit.1 passage
• Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies.1 passage
• Primary lung cancer in patients with previous malignancies: a nationwide study.1 passage
• Primary spontaneous pneumothorax: a cohort study of VATS with talc poudrage.1 passage
• Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages.1 passage
• Proactive tobacco treatment offering free nicotine replacement therapy and telephone counselling for socioeconomically disadvantaged smokers: a randomised clinical trial.1 passage
• Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.1 passage
• Production of reactive persulfide species in chronic obstructive pulmonary disease.1 passage
• Prognostic accuracy of a peripheral blood transcriptome signature in chronic hypersensitivity pneumonitis.1 passage
• Prognostic value of interferon-γ release assays, a population-based study from a TB low-incidence country.1 passage
• Programme, The University of Liverpool Cancer Research Centre, Liverpool, UKCorrespondence to Dr24 passages
• Progranulin aggravates pulmonary immunopathology during influenza virus infection.1 passage
• Progress in respiratory management of bulbar complications of motor neuron disease/amyotrophic lateral sclerosis? Simonds12 passages
• Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials.1 passage
• Prolonged controlled mechanical ventilation in humans triggers myofibrillar contractile dysfunction and myofilament protein loss in the diaphragm.1 passage
• Prospective community programme versus parent-driven care to prevent respiratory morbidity in children following hospitalisation with severe bronchiolitis or pneumonia.1 passage
• Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.1 passage
• Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol.1 passage
• Protective effect of breastfeeding on recurrent cough in adulthood.1 passage
• Protective effect of club cell secretory protein (CC-16) on COPD risk and progression: a Mendelian randomisation study.1 passage
• Psychological impact of genetic and clinical screening for pulmonary fibrosis on asymptomatic first-degree relatives of affected individuals.1 passage
• Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT).1 passage
• Psychometric validation of the needs assessment tool: progressive disease in interstitial lung disease.1 passage
• Pulmonary CCR21 passage
• Pulmonary complications for women with sickle cell disease in pregnancy: systematic review and meta-analysis.1 passage
• Pulmonary cysts identified on chest CT: are they part of aging change or of clinical significance?1 passage
• Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length.1 passage
• Pulmonary fibrosis in the era of stratified medicine.1 passage
• Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up.1 passage
• Pulmonary macrophages: key players in the innate defence of the airways.1 passage
• Pulmonary nodules and CT screening: the past, present and future33 passages
• Pulmonary nodules and CT screening: the past, present and future.1 passage
• Pulmonary rehabilitation, physical activity, respiratory failure and palliative respiratory care.1 passage
• Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study.1 passage
• Pulse arrival time, a novel sleep cardiovascular marker: the multi-ethnic study of atherosclerosis.1 passage
• Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores.1 passage
• Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study.1 passage
• Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass dynamic contrast-enhanced perfusion MRI.1 passage
• RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock.1 passage
• RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic.1 passage
• Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis.1 passage
• Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.1 passage
• Randomised controlled trial to investigate the use of high-frequency airway oscillations as1 passage
• Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial).1 passage
• Randomised sham-controlled trial of transcutaneous electrical stimulation in obstructive sleep apnoea.1 passage
• Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility).1 passage
• Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis.1 passage
• Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.1 passage
• Rapid decline in lung function is temporally associated with greater metabolically active adiposity in a longitudinal study of healthy adults.1 passage
• Rates of asthma exacerbations and mortality and associated factors in Uganda: a 2-year prospective cohort study.1 passage
• Raw milk consumption and other early-life farm exposures and adult pulmonary function in the Agricultural Lung Health Study.1 passage
• Recent TB transmission, clustering and predictors of large clusters in London, 2010-2012: results from first 3 years of universal MIRU-VNTR strain typing.1 passage
• Recovery from pneumonia requires efferocytosis which is impaired in smokers and those with low body mass index and enhanced by statins.1 passage
• Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections.1 passage
• Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates.1 passage
• Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension.1 passage
• Reduction in tuberculosis incidence in the UK from 2011 to 2015: a population-based study.1 passage
• Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries.1 passage
• Reference values for oxygen saturation from sea level to the highest human habitation in the Andes in acclimatised persons.1 passage
• Regenerative pharmacology for COPD: breathing new life into old lungs.1 passage
• Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.1 passage
• Relationship between heart failure and the risk of acute exacerbation of COPD.1 passage
• Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD.1 passage
• Relationship between pulmonary rehabilitation and care dependency in COPD.1 passage
• Reliability of methods to estimate the fraction of inspired oxygen in patients with acute respiratory failure breathing through non-rebreather reservoir bag oxygen mask.1 passage
• Relieving dyspnoea by non-invasive ventilation decreases pain thresholds in amyotrophic lateral sclerosis.1 passage
• Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis.1 passage
• Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study.1 passage
• Research in progress--LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group.1 passage
• Research in progress-electronic patient records: a new era.1 passage
• Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK).1 passage
• Resection rate of lung cancer in Teesside (UK) and Varese (Italy): a comparison after implementation of the National Cancer Plan.1 passage
• Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of target genes.1 passage
• Respiratory Biomedical Research Unit, Royal Brompton &32 passages
• Respiratory Biomedical Research Unit, Royal Brompton and29 passages
• Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19.1 passage
• Respiratory exacerbations are associated with muscle loss in current and former smokers.1 passage
• Respiratory follow-up of patients with COVID-19 pneumonia.1 passage
• Respiratory health and disease in a U.K. population-based cohort of 85 year olds: The Newcastle 85+ Study.1 passage
• Respiratory microbiota: addressing clinical questions, informing clinical practice Rogers36 passages
• Respiratory microbiota: addressing clinical questions, informing clinical practice.1 passage
• Respiratory mortality of childhood, adolescent and young adult cancer survivors.1 passage
• Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis.1 passage
• Respiratory syncytial virus (RSV): a scourge from infancy to old age.1 passage
• Respiratory viruses associated with community-acquired pneumonia in children: matched case-control study.1 passage
• Respiratory viruses in healthy infants and infants with cystic fibrosis: a prospective cohort study.1 passage
• Restrictive lung defects: parenchymal, chest wall and neuromuscular.1 passage
• Return to work after critical illness: a systematic review and meta-analysis.1 passage
• Return to work and lost earnings after acute respiratory distress syndrome: a 5-year prospective, longitudinal study of long-term survivors.1 passage
• Review of the British Thoracic Society Winter Meeting 2014, 3-5 December, London, UK.1 passage
• Review of the British Thoracic Society Winter Meeting 2015, 2-4 December, London, UK.1 passage
• Review of the British Thoracic Society Winter Meeting 2016, 7-9 December, London, UK.1 passage
• Review of the British Thoracic Society Winter Meeting 2017, 6-8 December 2017, London, UK.1 passage
• Review of the British Thoracic Society Winter Meeting 2018, 5-7 December 2018, London, UK.1 passage
• Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.1 passage
• Risk and impact of chronic cough in obese individuals from the general population.1 passage
• Risk factors for community-acquired pneumonia in adults in Europe: a literature review Torres Antoni 1Peetermans36 passages
• Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK).1 passage
• Risk factors for disease progression in idiopathic pulmonary fibrosis.1 passage
• Risk factors for situs defects and congenital heart disease in primary ciliary dyskinesia.1 passage
• Risk of asbestosis, mesothelioma, other lung disease or death among motor vehicle mechanics: a 45-year Danish cohort study.1 passage
• Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case-control study.1 passage
• Risk of fall in patients with COPD.1 passage
• Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies.1 passage
• Risk stratification based on screening history: the NELSON lung cancer screening study.1 passage
• Role of CT in assessing pleural malignancy prior to thoracoscopy.1 passage
• Role of NADPH oxidase-2 and oxidative stress in children exposed to passive smoking.1 passage
• Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunction.1 passage
• Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis.1 passage
• Role of extracellular vesicles in chronic lung disease.1 passage
• Role of habit in treatment adherence among adults with cystic fibrosis.1 passage
• Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial.1 passage
• Role of the IL-33/ST2 axis in cigarette smoke-induced airways remodelling in chronic obstructive pulmonary disease.1 passage
• Role of unfolded proteins in lung disease.1 passage
• SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures.1 passage
• SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis.1 passage
• SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.1 passage
• STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma.1 passage
• SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ.1 passage
• Safety of pulmonary function testing: data from 20 years.1 passage
• Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation.1 passage
• Scoring criteria for portable monitor recordings: a comparison of four hypopnoea definitions in a population-based cohort.1 passage
• Screening contacts of patients with extrapulmonary TB for latent TB infection.1 passage
• Screening for TB by sputum culture in high-risk groups in Copenhagen, Denmark: a novel and promising approach.1 passage
• Seasonal temperature variability and emergency hospital admissions for respiratory diseases: a population-based cohort study.1 passage
• Seasonal variation in incidence of sarcoidosis: a population-based study, 1976-2013.1 passage
• Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot.1 passage
• Secondary-care costs associated with lung cancer diagnosed at emergency hospitalisation in the United Kingdom.1 passage
• Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis.1 passage
• Secondhand smoke exposure and asthma outcomes among African-American and Latino children with asthma.1 passage
• Selection of eligible participants for screening for lung cancer using primary care data.1 passage
• Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial.1 passage
• Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome.1 passage
• Serum free testosterone and asthma, asthma hospitalisations and lung function in British adults.1 passage
• Severe organising pneumonia following COVID-19.1 passage
• Severe respiratory syncytial virus disease in preterm infants: a case of innate immaturity.1 passage
• Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia.1 passage
• Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS.1 passage
• Shift work is associated with positive COVID-19 status in hospitalised patients.1 passage
• Short lung transplant donor telomere length is associated with decreased CLAD-free survival.1 passage
• Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.1 passage
• Short-term association among meteorological variation, outdoor air pollution and acute bronchiolitis in children in a subtropical setting.1 passage
• Short-term clinical outcome of normotensive patients with acute PE and high plasma lactate.1 passage
• Should NICE reconsider the 2016 UK guidelines on TB contact tracing? A cost-effectiveness analysis of contact investigations in London.1 passage
• Simplified bedside assessment of pulmonary gas exchange in very preterm infants at 36 weeks' postmenstrual age.1 passage
• Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial.1 passage
• Six-week behaviour change intervention to reduce sedentary behaviour in people with chronic obstructive pulmonary disease: a randomised controlled trial.1 passage
• Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study.1 passage
• Sleep-disordered breathing and daytime postural stability.1 passage
• Sleep-disordered breathing and ventilatory chemosensitivity in first ischaemic stroke patients: a prospective cohort study.1 passage
• Small airway determinants of airflow limitation in chronic obstructive pulmonary disease.1 passage
• Smokers are less likely than non-smokers to seek help for a lung cancer 'alarm' symptom.1 passage
• Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.1 passage
• Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.1 passage
• Smoking uptake in UK children: analysis of the UK Millennium Cohort Study.1 passage
• Smoking, telomere length and lung function decline: a longitudinal population-based study.1 passage
• Social isolation and loneliness as risk factors for hospital admissions for respiratory disease among older adults.1 passage
• Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysis.1 passage
• Socio-environmental correlates of physical activity in patients with chronic obstructive pulmonary disease (COPD).1 passage
• Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and Wales.1 passage
• Sphingolipid, fatty acid and phospholipid metabolites are associated with disease severity and mTOR inhibition in lymphangioleiomyomatosis.1 passage
• Sphingosine kinase 1 regulates lysyl oxidase through STAT3 in hyperoxia-mediated neonatal lung injury.1 passage
• Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy.1 passage
• Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.1 passage
• Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis.1 passage
• Sputum microbiome profiling in COPD: beyond singular pathogen detection.1 passage
• Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.1 passage
• Sputum microbiota in adults with CF associates with response to inhaled tobramycin.1 passage
• Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.1 passage
• Stability of ARDS subphenotypes over time in two randomised controlled trials.1 passage
• State of the art review: from the seaside to the bedside: insights from comparative diving physiology into respiratory, sleep and critical care.1 passage
• State of the art thoracic ultrasound: intervention and therapeutics.1 passage
• Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort.1 passage
• Statin use and exacerbations in individuals with chronic obstructive pulmonary disease.1 passage
• Structural airway imaging metrics are differentially associated with persistent chronic bronchitis.1 passage
• Supervised pulmonary rehabilitation using minimal or specialist exercise equipment in COPD: a propensity-matched analysis.1 passage
• Supervised pulmonary tele-rehabilitation versus pulmonary rehabilitation in severe COPD: a randomised multicentre trial.1 passage
• Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: a case-control study.1 passage
• Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study.1 passage
• Survival of Australian lung cancer patients and the impact of distance from and attendance at a thoracic specialist centre: a data linkage study.1 passage
• Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference?1 passage
• Symptoms at lung cancer diagnosis are associated with major differences in prognosis.1 passage
• Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19.1 passage
• Systemic inflammation after critical illness: relationship with physical recovery and exploration of potential mechanisms.1 passage
• TB in healthcare workers in the UK: a cohort analysis 2009-2013.1 passage
• TB vaccine development: where are we and why is it so difficult?1 passage
• TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection.1 passage
• Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis.1 passage
• Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis.1 passage
• Targeted lung denervation for moderate to severe COPD: a pilot study.1 passage
• Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin.1 passage
• Teenager with chest pain and swollen neck: a leave-it-alone condition.1 passage
• Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial.1 passage
• Temperature variability and asthma hospitalisation in Brazil, 2000-2015: a nationwide case-crossover study.1 passage
• Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.1 passage
• Testing the effects of combining azithromycin with inhaled tobramycin for1 passage
• The British Thoracic Society guidelines on the investigation and management of pulmonary nodules.1 passage
• The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension.1 passage
• The Canadian Healthy Infant Longitudinal Development (CHILD) Study: examining developmental origins of allergy and asthma.1 passage
• The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer.1 passage
• The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference.1 passage
• The LungPath study: variation in the diagnostic and staging pathway for patients with lung cancer in England.1 passage
• The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD.1 passage
• The Study Team for Early Life Asthma Research (STELAR) consortium 'Asthma e-lab': team science bringing data, methods and investigators together.1 passage
• The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions.1 passage
• The association of body mass index, weight gain and central obesity with activity-related breathlessness: the Swedish Cardiopulmonary Bioimage Study.1 passage
• The clinical spectrum of pulmonary aspergillosis.1 passage
• The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case1 passage
• The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.1 passage
• The cyclin-dependent kinase inhibitor AT7519 accelerates neutrophil apoptosis in sepsis-related acute respiratory distress syndrome.1 passage
• The dangers of widespread nitric oxide screening for primary ciliary dyskinesia.1 passage
• The development and first validation of the Manchester Early Morning Symptoms Index (MEMSI) for patients with COPD.1 passage
• The dynamics of the pulmonary microbiome during mechanical ventilation in the intensive care unit and the association with occurrence of pneumonia.1 passage
• The effect of acute morphine on obstructive sleep apnoea: a randomised double-blind placebo-controlled crossover trial.1 passage
• The effect of diabetes control status on treatment response in pulmonary tuberculosis: a prospective study.1 passage
• The effect of diet in infancy on asthma in young adults: the Merthyr Allergy Prevention Study.1 passage
• The effect of different radiological models on diagnostic accuracy and lung cancer screening performance.1 passage
• The effect of early growth patterns and lung function on the development of childhood asthma: a population based study.1 passage
• The effect of oxidative stress polymorphisms on the association between long-term black carbon exposure and lung function among elderly men.1 passage
• The effect of radiographic emphysema in assessing lung cancer risk.1 passage
• The effects of growing up on a farm on adult lung function and allergic phenotypes: an international population-based study.1 passage
• The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.1 passage
• The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection.1 passage
• The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis.1 passage
• The impact of the 'hub and spoke' model of care for lung cancer and equitable access to surgery.1 passage
• The interaction between bronchoconstriction and cough in asthma.1 passage
• The long term effect of pulmonary tuberculosis on income and employment in a low income, urban setting.1 passage
• The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.1 passage
• The molecular targets of approved treatments for pulmonary arterial hypertension.1 passage
• The natural history of severe asthma and influences of early risk factors: a population-based cohort study.1 passage
• The not so innocent bystander: an unusual cause of progressive breathlessness.1 passage
• The obstructive sleep apnoea syndrome in adolescents.1 passage
• The presence or severity of pulmonary hypertension does not affect outcomes for single-lung transplantation.1 passage
• The prospective evaluation of the TB strain typing service in England: a mixed methods study.1 passage
• The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities.1 passage
• The quantitative link of lung clearance index to bronchial segments affected by bronchiectasis.1 passage
• The relationship between Helicobacter pylori seropositivity and COPD.1 passage
• The role of interleukin-33 in chronic rhinosinusitis.1 passage
• The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study.1 passage
• The short-term association between asthma hospitalisations, ambient temperature, other meteorological factors and air pollutants in Hong Kong: a time-series study.1 passage
• The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers.1 passage
• The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.1 passage
• The utility of exhaled nitric oxide in patients with suspected asthma.1 passage
• The utility of ultrasound-guided thoracentesis and pleural biopsy in undiagnosed pleural exudates.1 passage
• The validity of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis.1 passage
• Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe1 passage
• Thoracentesis outcomes: a 12-year experience.1 passage
• Thorax6721 passages
• Tidal changes in respiratory resistance are sensitive indicators of airway obstruction in children.1 passage
• Tidal changes on CT and progression of ARDS Cereda Maurizio 1Xin Yi 2Hamedani Hooman 2Bellani Giacomo 3Kadlecek Stephen 2Clapp Justin 1Guerra Luca 4Meeder Natalie 1Rajaei Jennia 2Tustison31 passages
• Tidal changes on CT and progression of ARDS.1 passage
• Time to first antibiotic and mortality in adults hospitalised with community-acquired pneumonia: a matched-propensity analysis.1 passage
• Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis.1 passage
• Timing of1 passage
• Timing of secondhand smoke, pet, dampness or mould exposure and lung function in adolescence.1 passage
• Tiotropium attenuates IL-13-induced goblet cell metaplasia of human airway epithelial cells.1 passage
• To drain or not to drain? Abscess or empyema?1 passage
• Tobacco and tobacco branding in films most popular in the UK from 2009 to 2017.1 passage
• Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia.1 passage
• Top 10 research priorities for people living with pulmonary fibrosis, their caregivers, healthcare professionals and researchers.1 passage
• Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.1 passage
• Towards a personalised treatment approach for asthma attacks.1 passage
• Transbronchial cryobiopsy in fibrosing interstitial lung disease: modifications of the procedure lead to risk reduction.1 passage
• Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesis.1 passage
• Transepithelial nasal potential difference in patients with, and at risk of acute respiratory distress syndrome.1 passage
• Translating the transcriptome into tools for the early detection and prevention of lung cancer.1 passage
• Treatment of complex airway stenoses using patient-specific 3D-engineered stents: a proof-of-concept study.1 passage
• Trends in paediatric asthma hospitalisations - differences between neighbouring countries.1 passage
• Tuberculosis associated with Triplet therapy for lung cancer.1 passage
• Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay.1 passage
• Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study.1 passage
• Tumour-associated neutrophils and loss of epithelial PTEN can promote corticosteroid-insensitive MMP-9 expression in the chronically inflamed lung microenvironment.1 passage
• Tumour-infiltrating bystander CD81 passage
• Turning subtypes into disease axes to improve prediction of COPD progression.1 passage
• UK Health Behaviour Research Centre, University College London, London, UK3 School of Public Health, Rutgers University, New Brunswick, USACorrespondence to Dr30 passages
• UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.1 passage
• UK trainee experience in interstitial lung disease: results from a British Thoracic Society survey.1 passage
• UK, London Research Institute, London, UK4 School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Perth, AustraliaCorrespondence to Dr29 passages
• US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.1 passage
• US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary.1 passage
• Ultrasound evaluation of diaphragm function in mechanically ventilated patients: comparison to phrenic stimulation and prognostic implications.1 passage
• Ultrasound-guided pneumothorax induction prior to local anaesthetic thoracoscopy.1 passage
• Understanding patient outcomes after acute respiratory distress syndrome: identifying subtypes of physical, cognitive and mental health outcomes.1 passage
• Underweight as a risk factor for respiratory death in the Whitehall cohort study: exploring reverse causality using a 45-year follow-up.1 passage
• Unit at the Royal Brompton &37 passages
• Unit at the Royal Brompton and44 passages
• Unit at the Royal Brompton, Harefield33 passages
• Unit of Royal Brompton and23 passages
• Unit of the Royal Brompton and33 passages
• Unit, Faculty of Medicine, University of Southampton, Southampton, UKCorrespondence to Professor29 passages
• Unit, Institute for Lung Health, University Hospitals of33 passages
• Unit, Kolding Hospital, Kolding, DenmarkCorrespondence to23 passages
• Unit, Royal Brompton &91 passages
• Unit, Royal Brompton Hospital, London, UKCorrespondence to Professor35 passages
• Unit, Royal Brompton and40 passages
• Unit, The Royal Brompton and78 passages
• Unit, University General Hospital Consortium, Valencia, Spain2 CIBERES, Health Institute32 passages
• Unit, University Hospital11 passages
• Unit, University of Southampton and University Hospital67 passages
• Units, Royal Brompton &30 passages
• Untargeted Molecular Analysis of Exhaled Breath as a Diagnostic Test for Ventilator-Associated Lower Respiratory Tract Infections (BreathDx).1 passage
• Updated BTS Adult Bronchiectasis Guideline 2018: a multidisciplinary approach to comprehensive care.1 passage
• Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection.1 passage
• Urban airborne particle exposure impairs human lung and blood1 passage
• Urbanisation and asthma in low-income and middle-income countries: a systematic review of the urban-rural differences in asthma prevalence.1 passage
• Urbanisation but not biomass fuel smoke exposure is associated with asthma prevalence in four resource-limited settings.1 passage
• Use of autologous1 passage
• Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).1 passage
• Use of inhaled corticosteroids and risk of acquiring1 passage
• Use of oscillatory positive expiratory pressure (OPEP) devices to augment sputum clearance in COPD: a systematic review and meta-analysis.1 passage
• Use of preclinical models for malignant pleural mesothelioma.1 passage
• Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage.1 passage
• Using digital technology for home monitoring, adherence and self-management in cystic fibrosis: a state-of-the-art review.1 passage
• Using hyperpolarized1 passage
• Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling.1 passage
• Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study.1 passage
• Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasis.1 passage
• Validation of a health-related quality of life instrument for primary ciliary dyskinesia (QOL-PCD).1 passage
• Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD.1 passage
• Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments.1 passage
• Variability in clinicians' opinions regarding fitness to drive in patients with obstructive sleep apnoea syndrome (OSAS).1 passage
• Variation in lung cancer resources and workload: results from the first national lung cancer organisational audit.1 passage
• Variation in oral microbiome is associated with future risk of lung cancer among never-smokers.1 passage
• Ventilation inhomogeneity in infants with recurrent wheezing.1 passage
• Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort.1 passage
• Vitamin D deficiency and TB disease phenotype.1 passage
• Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS).1 passage
• Vitamin D for secondary prevention of acute wheeze attacks in preschool and school-age children.1 passage
• Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials.1 passage
• What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis.1 passage
• What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?1 passage
• What happens to patients with COPD with long-term oxygen treatment who receive mechanical ventilation for COPD exacerbation? A 1-year retrospective follow-up study.1 passage
• What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experiment.1 passage
• Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.1 passage
• Which intravenous bronchodilators are being administered to children presenting with acute severe wheeze in the UK and Ireland?1 passage
• Zinc supplementation ameliorates lung injury by reducing neutrophil recruitment and activity.1 passage
• β1 passage
• β-Blockers are associated with a reduction in COPD exacerbations.1 passage
• β-Blockers, heart disease and COPD: current controversies and uncertainties.1 passage